Systemic Low Dose Corticosteroid Improves Early Postoperative Knee Function and Pain Intensity in Patients Undergoing Unilateral Total Knee Arthroplasty: A Blinded Controlled Randomized Clinical Trial. [PDF]
Ebrahimzadeh MH +10 more
europepmc +1 more source
Development of a standardized murine model for investigating cholesterol crystallization and deposition in the gallbladder wall: effects of dietary cholesterol and pharmacological modulation. [PDF]
Gao X, Xu C, Gao W, Liu S, Zheng Y.
europepmc +1 more source
Randomized open-label non-inferiority trial of paracetamol or celecoxib for patients with chronic low back pain. [PDF]
Hayashi K +18 more
europepmc +1 more source
COX-2/PGE<sub>2</sub> axis blockade with celecoxib enhances anti-PD-1 efficacy by activating natural killer cells for residual hepatocellular carcinoma after radiofrequency ablation. [PDF]
Lei Y +9 more
europepmc +1 more source
Efficacy and safety of low-dose celecoxib in patients with mild to moderate knee osteoarthritis: a protocol for a single-center, randomized, double-blind, parallel-group controlled trial. [PDF]
He J, Yang D, Guo J, Xu P.
europepmc +1 more source
A randomised pilot trial of perioperative propranolol combined with celecoxib versus standard of care in stage III melanoma: The ProCel study protocol. [PDF]
Selvaraj KJ +10 more
europepmc +1 more source
In vitro celecoxib supplementation impacts the functional capacities of the gut microbiota [PDF]
Calatayud Arroyo, Marta +7 more
core +1 more source
Celecoxib in oncology: targeting the COX-2/PGE<sub>2</sub> axis to reprogram the tumor immune microenvironment and enhance multimodal therapy. [PDF]
Kuang B +5 more
europepmc +1 more source
In-line monitoring of compaction properties on a rotary tablet press during tablet manufacturing of hot-melt extruded amorphous solid dispersions [PDF]
De Beer, Thomas +7 more
core +2 more sources
Ly6G<sup>+</sup> granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis. [PDF]
Sharma P +21 more
europepmc +1 more source

